For research and laboratory use only. Not for human or veterinary consumption.

This product is sold for research purposes only. It is not intended for human consumption, diagnosis, treatment, cure, or prevention of any disease. Purchaser acknowledges that this material is for laboratory research use only.

Analogs

99.99% Purity

10mg lyophilized vial

CJC-1295 / Ipamorelin (No DAC)

CJC-1295 (No DAC) / Ipamorelin is a dual synthetic laboratory reagent formulation consisting of two structurally distinct laboratory reagent with defined amino acid sequences. The CJC-1295 component is supplied without Drug Affinity Complex (DAC) modification. Intended exclusively for research and analytical applications.

Quantity
$79.99 Bundle price $79.99
Quantity Options
Order within to ship today Cutoff 1:00 AM your time.
Free shipment protection ? Covers lost, stolen, or damaged packages at no extra cost. Just email support@elev-8labs.com and we'll replace it or refund you.
Overnight shipping available

We accept

🧪

Compound Information

Technical specifications

🔬 CJC-1295 (No DAC)

GHRH Analog Component

Other names
Mod GRF 1-29, Modified GRF
Type
GHRH analog
Amino Acids
29
Molecular Weight
~3,367 g/mol
Mechanism
GHRH receptor agonist
Half-life (No DAC)
30 min - 2 hours

💊 Ipamorelin

Selective GHRP Component

Selective GHRP Component
Growth hormone secretagogue
Amino Acids
5 (pentapeptide)
Molecular Weight
711.85 g/mol
Sequence
Aib-His-D-2-Nal-D-Phe-Lys-NH2
Mechanism
Ghrelin receptor (GHSR-1a) agonist
Selectivity
No cortisol/prolactin elevation

📋 Blend Information

Why This Combination

Synergistic GH release Dual-pathway activation

Typical ratio
1:1 by weight
Combined half-life
1-2 hours (functional)
Synergy factor
~2.7× vs single pathway
Route
Subcutaneous injection

📚

Sources & References

Peer-reviewed research

Journal of Clinical Endocrinology & Metabolism
Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-1295, a Long-Acting Analog of GH-Releasing Hormone, in Healthy Adults
2006 • DOI: 10.1210/jc.2005-1702 • PMID: 16352683 Teichman SL, Neale A, Lawrence B et al.
European Journal of Endocrinology
Ipamorelin, the first selective growth hormone secretagogue
1998 • DOI: 10.1530/eje.0.1390552 • PMID: 9849822 Raun K, Hansen BS, Johansen NL et al.
Journal of Clinical Endocrinology & Metabolism
On the actions of the growth hormone-releasing hexapeptide, GHRP
1991 • PMID: 1919399 Bowers CY, Reynolds GA, Durham D et al.
Translational Andrology and Urology
A Review of Growth Hormone Secretagogues
2018 • DOI: 10.21037/tau.2018.06.09 • PMID: 30186644 Sigalos JT, Pastuszak AW View Source
Journal of Clinical Endocrinology & Metabolism
Effects of Growth Hormone and Its Secretagogues on Bone
1998 • PMID: 9851737 Svensson J, Ohlsson C, Jansson JO et al.
Journal of Clinical Endocrinology & Metabolism
Once-Daily Administration of CJC-1295, a Long-Acting Growth Hormone-Releasing Hormone (GHRH) Analog, Normalizes Growth in the GHRH Knockout Mouse
2006 • DOI: 10.1210/jc.2005-2371 • PMID: 16670169 Alba M, Fintini D, Sagazio A et al. View Source

Related Products

10mg lyophilized vial

Tesamorelin — 44-residue synthetic GHRH analog. CAS 218949-48-5 · MW 5,195.78 g/mol · 99.6% purity

10mg lyophilized vial

A 5-amino acid pentapeptide that selectively stimulates growth hormone release through ghrelin receptor (GHSR-1a) activation

10mg lyophilized vial

An 83-amino acid synthetic analog of human insulin-like growth factor 1 with reduced binding protein

Certificate of Analysis

Researcher verification

Elev-8 Labs sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.

By proceeding, you affirm the statements above are true: products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.